HeinzelbeckerJ,KatzmarzikM,Weiss C, 2013.During twenty years of Cisplatin-based therapy the face of nonseminomatous testicular germ cell tumors is still changing: an evaluation of presentation, management, predictive factors and survival,Int Braz J Urol 39 10 -21
MeeksJJ,SheinfeldJ,EggenerSE, 2012.Environmental toxicology of testicular cancer,Urol Oncol 30 212 -5
EinhornL, 1990.Treatment of testicular cancer: a new and improved model,J Clin Oncol 8 1777 -81
BokemeyerC,KollmannsbergerC,Stenning S, 2004.Metastatic seminoma treated with either single agent carboplatin or cisplatin-based combination chemotherapy: a pooled analysis of two randomised trials,Br J Cancer 91 683 -7
Garcia-del-MuroX,MarotoP,GumàJ, 2008.Chemotherapy as an alternative to radiotherapy in the treatment of stage IIA and IIB testicular seminoma: a Spanish germ cell cancer group study,J Clin Oncol 2 5416 -21
TravisLB,FossaSD,SchonfeldSJ, 2005.576 testicular cancer patients: focus on long-term survivor,J Natl Cancer Inst 97 1354 -65
SteinerH,MüllerT,GozziC, 2006.Two cycles of cisplatin-based chemotherapy for low-volume retroperitoneal stage II nonseminomatous germ cell tumours,B J U Int 98 349 -52
HaugnesHS,WethalT,AassN., 2010.Cardiovascular risk factors and morbidity in long-term survivors of testicular cancer: a 20-year follow-up study,J Clin Oncol 28 4649 -57
KatherineAM,SusanSD,AliceJS, 2003.Trends in the incidence of testicular germ cell tumors in the United States,Cancer 97 63 -70
LoehrerPJ,GoninR,NicholsCR, 1998.Vinblastine plus ifosfamide plus cisplatin as initial salvage therapy in recurrent germ cell tumor,J Clin Oncol 16 2500 -04
McCaffreyJA,MazumdarM,Bajorin DF, .Ifosfamide- and cisplatin-containing chemotherapy as first-line salvage therapy in germ cell tumors: response and survival,J Clin Oncol 199 2559 -63
KondaguntaGV,BacikJ,DonadioA, 2005.Combination of paclitaxel, ifosfamide, and cisplatin is an effective second-line therapy for patients with relapsed testicular germ cell tumors,J Clin Oncol 2 6549 -55
BajorinDF,SarosdyMF,PfisterDG, 1993.Randomized trial of etoposide and cisplatin versus etoposide and carboplatin in patients with good-risk germ cell tumors: a multiinstitutional study,J Clin Oncol 11 598 -606
HorwichA,SleijferDT,FossaSD, 1997.Randomized trial of bleomycin, etoposide, and cisplatin compared with bleomycin, etoposide, and carboplatin in good-prognosis metastatic nonseminomatous germ cell cancer: a multiinstitutional medical research council/European organization for research and treatment of cancer tria,J Clin Oncol 15 1844 -52
De WitR,RobertsJT,WilkinsonPM, 2001.Equivalence of three or four cycles of bleomycin, etoposide, and cisplatin chemotherapy and of a 3- or 5-day schedule in good-prognosis germ cell cancer: a randomized study of the European Organization for Research and Treatment of Cancer Genitourinary Tract Cancer Cooperative Group and the Medical Research Council,J Clin Oncol 19 1629 -40
TonerGC,StocklerMR,Boyer MJ, 2001.Comparison of two standard chemotherapy regimens for good-prognosis germcell tumours: a randomised trial,Australian and New Zealand Germ Cell Trial Grou. Lancet 357 739 -45
CulineS,KerbratP,KramarA, 2007.Refining the optimal chemotherapy regimen for good-risk metastatic nonseminomatous germ-cell tumors: a randomized trial of the Genito-Urinary Group of the French Federation of Cancer Centers (GETUG T93BP,Ann Oncol 18 917 -24
DaugaardG,NielsenH,BruunB., 1993.Infections in patients treated with high-dose chemotherapy for germ cell tumours,Eur J Cancer 29 2220 -2
HansenSW,Helweg-LarsenS,TrojaborgW, 1989.Long-term neurotoxicity in patients treated with cisplatin, vinblastine, and bleomycin for metastatic germ cell cancer,J Clin Oncol 7 1457 -61
BokemeyerC,BergerCC,KuczykMA, 1996.Evaluation of long-term toxicity after chemotherapy for testicular cancer,J Clin Oncol 14 2923 -32